Preventative Treatment to Reduce Risk of Alzheimer’s Disease, Using Non-Steroidal Anti-Inflammatory Drugs? (NHS Choices / Journal of Alzheimer’s Disease)


A recent article suggests that use of nonsteroidal anti-inflammatory drugs (NSAIDs) might help to reduce the risk of developing Alzheimer’s Disease, if prescription were to be commenced years before clinical signs were to develop.

An NHS Choices Behind the Headlines critical appraisal examines this paper, and offers a sense of perspective by discussing the remaining uncertainties.

Full Text Link


Claims ibuprofen ‘will wipe out Alzheimer’s’ are misleading. London: NHS Choices; Behind the Headlines, March 28th 2018.

This relates to:

Full Text Link


McGeer, PL. Guo, JP. And] Lee, M. [et al] (2018). Alzheimer’s Disease can be spared by nonsteroidal anti-inflammatory drugs. Journal of Alzheimer’s Disease. March 13th 2018; 62(3): 1219-1222.

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Pharmacological Treatments, Quick Insights, Universal Interest and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.